当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Questions regarding the CONCERN trial – Authors' reply
The Lancet ( IF 168.9 ) Pub Date : 2018-01-13 , DOI: 10.1016/s0140-6736(17)32428-5
Francis K L Chan , Jessica Y L Ching , Yee Kit Tse , Moe H Kyaw

We thank Ricky Turgeon for his Correspondence regarding our CONCERN trial1 on the gastrointestinal safety of celecoxib plus esomeprazole versus naproxen and esomeprazole in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding.

中文翻译:

有关CONCERN审判的问题-作者的答复

我们感谢Ricky Turgeon对我们的CONCERN试验1的通讯,该试验关于celecoxib联合esomeprazole与naproxen和esomeprazole在患有上消化道出血的心血管疾病和关节炎患者中的胃肠道安全性。
更新日期:2018-01-12
down
wechat
bug